Grading and Prognostication of Neuroendocrine Tumors of the Pancreas: A Comparison Study of Ki67 and PHH3
- PMID: 28651471
- PMCID: PMC5490847
- DOI: 10.1369/0022155417708186
Grading and Prognostication of Neuroendocrine Tumors of the Pancreas: A Comparison Study of Ki67 and PHH3
Abstract
Grading of pancreatic neuroendocrine tumors (pNETs) is currently based on mitotic rate and Ki67 proliferation index. Phosphohistone-H3 (PHH3) is an effective marker for mitosis that has been proposed to use in grading various NETs. It remains unclear which method more accurately predicts grade and clinical outcome. Cases of pNET were evaluated using immunohistochemical stains for Ki67 and PHH3. In addition, each case was evaluated for necrosis, lymphovascular invasion, and perineural invasion and compared with stage. R project statistical analysis was used for comparisons. Sixty-three cases were included in the study including 29 males and 34 females (M:F 0.9) with a median age of 59 years (ranging 34-84). There was not a significant discrepancy in the stratification of tumor grades for Ki67 and PHH3. PHH3 significantly predicted lymph node metastasis ( p=0.041). Necrosis correlated with overall survival ( p=0.017). The results suggest that PHH3 is an effective marker for determining mitotic activity and can be used alternative to Ki67. In addition, necrosis may be included in the reporting of pNET as it may play a prognostic role. Larger scale studies are warranted to understand the biology and behavior of these tumors.
Keywords: Ki67; PHH3; mitosis; neuroendocrine tumor; pancreas.
Conflict of interest statement
Figures


Similar articles
-
Mitotic count by phosphohistone H3 immunohistochemical staining predicts survival and improves interobserver reproducibility in well-differentiated neuroendocrine tumors of the pancreas.Am J Surg Pathol. 2015 Jan;39(1):13-24. doi: 10.1097/PAS.0000000000000341. Am J Surg Pathol. 2015. PMID: 25353284
-
The Impact of Phosphohistone-H3-Assisted Mitotic Count and Ki67 Score in the Determination of Tumor Grade and Prediction of Distant Metastasis in Well-Differentiated Pancreatic Neuroendocrine Tumors.Endocr Pathol. 2016 Jun;27(2):162-70. doi: 10.1007/s12022-016-9424-9. Endocr Pathol. 2016. PMID: 26936845
-
The potential value of phosphohistone-h3 mitotic index determined by digital image analysis in the assessment of pancreatic endocrine tumors in fine-needle aspiration cytology specimens.Acta Cytol. 2013;57(3):291-5. doi: 10.1159/000350885. Epub 2013 Apr 25. Acta Cytol. 2013. PMID: 23635399
-
Paradoxical results obtained with Ki67-labeling and PHH3-mitosis index in glial tumors: a literature analysis.Clin Neuropathol. 2017 Nov/Dec;36(6):272-282. doi: 10.5414/NP301028. Clin Neuropathol. 2017. PMID: 28853695 Review.
-
Phosphorylated Histone H3 (PHH3) as a Novel Cell Proliferation Marker and Prognosticator for Meningeal Tumors: A Short Review.Appl Immunohistochem Mol Morphol. 2018 Oct;26(9):627-631. doi: 10.1097/PAI.0000000000000499. Appl Immunohistochem Mol Morphol. 2018. PMID: 28777144 Review.
Cited by
-
An miRNA Signature Predicts Grading of Pancreatic Neuroendocrine Neoplasms.Cancer Genomics Proteomics. 2023 Mar-Apr;20(2):154-164. doi: 10.21873/cgp.20370. Cancer Genomics Proteomics. 2023. PMID: 36870693 Free PMC article.
-
Potential of Proliferative Markers in Pancreatic Cancer Management: A Systematic Review.Health Sci Rep. 2025 Mar 5;8(3):e70412. doi: 10.1002/hsr2.70412. eCollection 2025 Mar. Health Sci Rep. 2025. PMID: 40051490 Free PMC article. Review.
-
The Role of Conventionally Fractionated Radiotherapy and Stereotactic Radiotherapy in the Treatment of Carcinoid Tumors and Large-Cell Neuroendocrine Cancer of the Lung.Cancers (Basel). 2021 Dec 30;14(1):177. doi: 10.3390/cancers14010177. Cancers (Basel). 2021. PMID: 35008341 Free PMC article. Review.
-
Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies.Expert Rev Anticancer Ther. 2019 Dec;19(12):1029-1050. doi: 10.1080/14737140.2019.1693893. Epub 2019 Nov 27. Expert Rev Anticancer Ther. 2019. PMID: 31738624 Free PMC article. Review.
-
Information mismatch in PHH3-assisted mitosis annotation leads to interpretation shifts in H&E slide analysis.Sci Rep. 2024 Nov 1;14(1):26273. doi: 10.1038/s41598-024-77244-6. Sci Rep. 2024. PMID: 39487193 Free PMC article.
References
-
- Yang Z, Tang LH, Klimstra DS. Gastroenteropancreatic neuroendocrine neoplasms: historical context and current issues. Semin Diagn Pathol. 2013;30:186–96. - PubMed
-
- Ries LAG. Cancer survival among adults: U.S. SEER program, 1988-2001, patient and tumor characteristics. Bethesda, MD: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute; 2007.
-
- Fraenkel M, Kim MK, Faggiano A, Valk GD. Epidemiology of gastroenteropancreatic neuroendocrine tumours. Best Pract Res Clin Gastroenterol. 2012;26:691–703. - PubMed
-
- Lawrence B, Gustafsson BI, Chan A, Svejda B, Kidd M, Modlin IM. The epidemiology of gastroenteropancreatic neuroendocrine tumors. Endocrinol Metab Clin North Am. 2011;40:1–18, vii. - PubMed
-
- Bosman F, Carneiro F, Hruban R, Theise N. WHO classification of tumours of the digestive system. Lyon, France: IARC Press; 2010.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical